Your browser doesn't support javascript.
loading
Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?
Stephenson, Diane; Ollivier, Cecile; Brinton, Roberta; Barrett, Jeffrey.
Affiliation
  • Stephenson D; Critical Path Institute, Tucson, Arizona, USA.
  • Ollivier C; Critical Path Institute, Tucson, Arizona, USA.
  • Brinton R; Center for Innovation in Brain Sciences, University of Arizona Health Sciences, Tucson, Arizona, USA.
  • Barrett J; Critical Path Institute, Tucson, Arizona, USA.
Clin Pharmacol Ther ; 111(4): 799-806, 2022 04.
Article in En | MEDLINE | ID: mdl-35034352
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Dystrophy, Duchenne / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Dystrophy, Duchenne / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States